Friday, January 14 (16)

7:00 AM - 8:00 AM

Device Troubleshooting for APPs

Advance Practice Providers are heavily involved in the care of patients pre- and post-implant of neuromodulation devices. APPs need to be aware of best practices for trouble shooting issues or complications related to neuromodulation and remain up to date on the newest technology available for patient's suffering from conditions amenable to neuromodulation therapy.

Speaker:

Christy A. Gomez Hupe, DNP

Molly Liter

Lauren Cimino, APRN-CNP

Teresita Devera, MSN, CRNP, ANP-BC

Chelsey Hoffmann, PA-C, MS, RD

3:45 PM - 5:15 PM

Intrathecal Drug Delivery: From Pharmacy to Pumps

Targeted intrathecal drug delivery systems have long been utilized as a terminal therapeutic option for patients with chronic pain. There have been several exciting developments both in the underlying mechanisms of delivery and within the pharmacologic options available that warrant dissemination amongst pain specialists. This session will discuss the standardized approach and theory behind anatomical target, novel pharmacology in the field for both malignant and nonmalignant pain, and finally the pharmacodynamics and kinetics of intrathecal drug delivery.

Speaker:

Rushna P. Ali, MD

Mark R. Jones, MD

Tammy L. Dann, DO,MPH

Tony L. Yaksh, PhD

Ann C. Shah, MD

3:45 PM - 5:15 PM

Identifying Alternative Cells Involved in SCS Therapy Featured

While the mechanisms of action of neuromodulation devices, in particular Spinal Cord Stimulators have been historically connected with the Gate Control theory (Wall and Melzack, 1965), recent technological advances have been challenging this statement. For few years now, Sub-perception SCS in various forms, including burst and higher frequencies, has been thoroughly discussed at Neuromodulation conferences. More recently, emerging research, based on preclinical animal data as well as complex computational modeling and algorithms, has started clinical validation of new SCS mechanisms of action exploring the roles of surround inhibition neurons as well as that of glial cells as they interact with the pain neural network. Physicians and scientists in the Neuromodulation space need to understand these new SCS mechanisms in order to inform further research and create robust and reproducible patients' plans of care based on true evidenced based research.

Speaker:

Magdalena M. Anitescu, MD PhD

Kathleen Meacham, MD, PhD

Sam S. Eldabe, MB ChB FRCA FFPMRCA

Joshua M. Rosenow, MD,FACS

Warren M. Grill, PhD

Mark Wallace, MD

3:45 PM - 5:15 PM

Emerging Technologies and Indications: Peripheral Nerve Stimulation

This session will present recent technological advancements and novel indications related to peripheral nerve stimulation. The technological advancements will include novel stimulation waveforms, electrode technologies, and control algorithms. The session will also present emerging indications of peripheral nerve stimulation, such as sensory restoration and detrusor underactivity.

Speaker:

Lee E. Fisher, PhD

Nicole A. Pelot, PHD

Emily L. Graczyk, PhD

Tim M. Bruns, PhD

Sridevi V. Sarma, PhD

Kip A. Ludwig, PHD

Subscribe to this RSS feed